Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for
Status:
Active, not recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Stroke is an acute focal injury of the central nervous system caused by cerebral vessels. One
in every four people is affected by stroke at different times in life. Globally, stroke is
the second leading cause of death and third leading cause of disability in adults. we
hypothesized that in patients with acute large vessel occlusive ischemic stroke treated with
mechanical thrombectomy, the infusion of 20% human serum albumin solution into the
revascularization area can exert a stronger neuroprotective effect.